Safety and Efficacy of Tirzepatide as an Add-On Treatment to a Single Oral Antihyperglycaemic Medication in Patients With Type 2 Diabetes in Japan
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
Lancet Diabetes Endocrinol 2022 Jul 29;[EPub Ahead of Print], T Kadowaki, R Chin, A Ozeki, T Imaoka, Y OgawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.